PROJECTED LONG-TERM OUTCOMES IN PATIENTS WITH TYPE 1 DIABETES MELLITUS TREATED WITH FASTER-ACTING INSULIN ASPART VERSUS CONVENTIONAL INSULIN ASPART IN THE UK SETTING

被引：0
|
作者：
Russell-Jones, D. [1 ]
Buchs, S. [2 ]
Jensen, M. M. [2 ]
Hunt, B. [3 ]
Valentine, W. J. [3 ]
Heller, S. [4 ]
机构：
[1] Royal Surrey Cty Hosp, Guildford, Surrey, England
[2] Novo Nordisk AS, Soborg, Denmark
[3] Ossian Hlth Econ & Commun, Basel, Switzerland
[4] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1869
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB39
引用
收藏
页码：A671 / A671
页数：1
相关论文
共 50 条
  • [31] Effectiveness of Faster Aspart versus Insulin Aspart in Children with Type 1 Diabetes: A Meta-Analysis
    Wei, Jie
    Wang, Yueer
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (01) : 23 - 34
  • [32] Fast-Acting Insulin aspart (faster aspart) - Clinical Data on Application in Type 1 and 2 Diabetes
    Jaeckel, E.
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (06): : 313 - 319
  • [33] Comparison of faster-acting aspart with insulin aspart under conditions mimicking underestimation or missed meal boluses in type 1 diabetes using closed-loop insulin delivery
    Thabit, Hood
    Mubita, Womba
    Rubio, Jose
    Karuppan, Mini
    Schofield, Jonathan
    Willinska, Malgorzata E.
    Hovorka, Roman
    Leelarathna, Lalantha
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 1121 - 1124
  • [34] Faster-acting insulin aspart: faster offset of exposure and action in addition to faster onset in subjects with type 1 diabetes using continuous subcutaneous insulin infusion
    Zijlstra, E.
    Heise, T.
    Nosek, L.
    Rikte, T.
    Haahr, H.
    DIABETOLOGIA, 2016, 59 : S98 - S99
  • [35] Double-blind mealtime faster-acting insulin aspart vs insulin aspart in basal-bolus improves glycaemic control in Type 1 diabetes: the onset 1 trial
    Russell-Jones, D.
    Bode, B. W.
    De Block, C.
    Franek, E.
    Heller, S.
    Mathieu, C.
    Philis-Tsimikas, A.
    Rose, L.
    Woo, V.
    Osterskov, A. B.
    Graungaard, T.
    Bergenstal, R.
    DIABETIC MEDICINE, 2017, 34 : 8 - 8
  • [36] EARLIER ONSET OF EXPOSURE AND GREATER EARLY PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS FOR FASTER-ACTING INSULIN ASPART VERSUS INSULIN ASPART USING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    Heise, T.
    Zijlstra, E.
    Rikte, T.
    Nosek, L.
    Haahr, H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A20 - A20
  • [37] Higher Early Insulin Exposure and Greater Early Glucose-Lowering Effect with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Mellitus (T1DM)
    Haahr, Hanne
    Hoevelmann, Ulrike
    Brondsted, Lise
    Adrian, Charlotte L.
    Nosek, Leszek
    Heise, Tim
    DIABETES, 2014, 63 : A233 - A233
  • [38] Glycaemic efficacy and safety of mealtime faster-acting insulin aspart administered by injection as compared to insulin aspart in people with diabetes mellitus: A meta-analysis of randomized controlled trials
    Pal, Rimesh
    Banerjee, Mainak
    Bhadada, Sanjay Kumar
    DIABETIC MEDICINE, 2021, 38 (03)
  • [39] Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial
    Buse, John B.
    Carlson, Anders L.
    Komatsu, Mitsuhisa
    Mosenzon, Ofri
    Rose, Ludger
    Liang, Bo
    Buchholtz, Kristine
    Horio, Hiroshi
    Kadowaki, Takashi
    DIABETES OBESITY & METABOLISM, 2018, 20 (12): : 2885 - 2893
  • [40] Double-blind mealtime faster-acting insulin aspart improves glycaemic control with superior reduction in postprandial glucose excursions vs insulin aspart in type 1 diabetes: onset® 1
    Russell-Jones, D.
    Bode, B. W.
    De Block, C.
    Franek, E.
    Heller, S.
    Mathieu, C.
    Philis-Tsimikas, A.
    Rose, L.
    Woo, V.
    Osterskov, A. B.
    Graungaard, T.
    Bergenstal, R. M.
    DIABETOLOGIA, 2016, 59 : S6 - S6
12345